Cargando…

Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time

BACKGROUND: Little is known about risk factors for chronic and mucoid Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) adults, and whether the prevalence is changing. METHODS: We employed a retrospective cohort to analyze data from a single adult CF center (2002 to 2012). Regression mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Crull, Mathew R., Ramos, Kathleen J., Caldwell, Ellen, Mayer-Hamblett, Nicole, Aitken, Moira L., Goss, Christopher H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142409/
https://www.ncbi.nlm.nih.gov/pubmed/27927212
http://dx.doi.org/10.1186/s12890-016-0333-y
_version_ 1782472770263711744
author Crull, Mathew R.
Ramos, Kathleen J.
Caldwell, Ellen
Mayer-Hamblett, Nicole
Aitken, Moira L.
Goss, Christopher H.
author_facet Crull, Mathew R.
Ramos, Kathleen J.
Caldwell, Ellen
Mayer-Hamblett, Nicole
Aitken, Moira L.
Goss, Christopher H.
author_sort Crull, Mathew R.
collection PubMed
description BACKGROUND: Little is known about risk factors for chronic and mucoid Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) adults, and whether the prevalence is changing. METHODS: We employed a retrospective cohort to analyze data from a single adult CF center (2002 to 2012). Regression models were used to assess independent predictors and change in prevalence of chronic and mucoid Pa infection over time. RESULTS: The odds ratio of mucoid Pa infection was significantly less in individuals with better baseline lung function (OR 0.84,95%CI:0.77–0.92) and those diagnosed after the age of 25 (OR 0.21, 95%CI:0.05–0.95). The prevalence of chronic Pa and mucoid Pa decreased during the time interval. After adjusting for confounders, the observed decrease in chronic and mucoid Pa between 2002 and 2012 was no longer significant. CONCLUSIONS: The prevalence of chronic and mucoid Pa is decreasing. Larger studies are needed to confirm these regional trends and their significance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12890-016-0333-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5142409
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51424092016-12-15 Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time Crull, Mathew R. Ramos, Kathleen J. Caldwell, Ellen Mayer-Hamblett, Nicole Aitken, Moira L. Goss, Christopher H. BMC Pulm Med Research Article BACKGROUND: Little is known about risk factors for chronic and mucoid Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) adults, and whether the prevalence is changing. METHODS: We employed a retrospective cohort to analyze data from a single adult CF center (2002 to 2012). Regression models were used to assess independent predictors and change in prevalence of chronic and mucoid Pa infection over time. RESULTS: The odds ratio of mucoid Pa infection was significantly less in individuals with better baseline lung function (OR 0.84,95%CI:0.77–0.92) and those diagnosed after the age of 25 (OR 0.21, 95%CI:0.05–0.95). The prevalence of chronic Pa and mucoid Pa decreased during the time interval. After adjusting for confounders, the observed decrease in chronic and mucoid Pa between 2002 and 2012 was no longer significant. CONCLUSIONS: The prevalence of chronic and mucoid Pa is decreasing. Larger studies are needed to confirm these regional trends and their significance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12890-016-0333-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-07 /pmc/articles/PMC5142409/ /pubmed/27927212 http://dx.doi.org/10.1186/s12890-016-0333-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Crull, Mathew R.
Ramos, Kathleen J.
Caldwell, Ellen
Mayer-Hamblett, Nicole
Aitken, Moira L.
Goss, Christopher H.
Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
title Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
title_full Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
title_fullStr Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
title_full_unstemmed Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
title_short Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
title_sort change in pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142409/
https://www.ncbi.nlm.nih.gov/pubmed/27927212
http://dx.doi.org/10.1186/s12890-016-0333-y
work_keys_str_mv AT crullmathewr changeinpseudomonasaeruginosaprevalenceincysticfibrosisadultsovertime
AT ramoskathleenj changeinpseudomonasaeruginosaprevalenceincysticfibrosisadultsovertime
AT caldwellellen changeinpseudomonasaeruginosaprevalenceincysticfibrosisadultsovertime
AT mayerhamblettnicole changeinpseudomonasaeruginosaprevalenceincysticfibrosisadultsovertime
AT aitkenmoiral changeinpseudomonasaeruginosaprevalenceincysticfibrosisadultsovertime
AT gosschristopherh changeinpseudomonasaeruginosaprevalenceincysticfibrosisadultsovertime